These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8246233)

  • 1. Inhibitors of cholesterol biosynthesis. 1. 3,5-Dihydroxy-7-(N-imidazolyl)-6-heptenoates and -heptanoates, a novel series of HMG-CoA reductase inhibitors.
    Chan C; Bailey EJ; Hartley CD; Hayman DF; Hutson JL; Inglis GG; Jones PS; Keeling SE; Kirk BE; Lamont RB
    J Med Chem; 1993 Nov; 36(23):3646-57. PubMed ID: 8246233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of cholesterol biosynthesis. 2. 3,5-Dihydroxy-7-(N-pyrrolyl)-6-heptenoates, a novel series of HMG-CoA reductase inhibitors.
    Procopiou PA; Draper CD; Hutson JL; Inglis GG; Ross BC; Watson NS
    J Med Chem; 1993 Nov; 36(23):3658-62. PubMed ID: 8246234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMG-CoA reductase inhibitors: design, synthesis, and biological activity of tetrahydroindazole-substituted 3,5-dihydroxy-6-heptenoic acid sodium salts.
    Connolly PJ; Westin CD; Loughney DA; Minor LK
    J Med Chem; 1993 Nov; 36(23):3674-85. PubMed ID: 8246237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of methanesulfonamide pyrimidine- and N-methanesulfonyl pyrrole-substituted 3,5-dihydroxy-6-heptenoates, a novel series of HMG-CoA reductase inhibitors.
    Watanabe M; Koike H; Ishiba T; Okada T; Seo S; Hirai K
    Bioorg Med Chem; 1997 Feb; 5(2):437-44. PubMed ID: 9061208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Aoki T; Nishimura H; Nakagawa S; Kojima J; Suzuki H; Tamaki T; Wada Y; Yokoo N; Sato F; Kimata H; Kitahara M; Toyoda K; Sakashita M; Saito Y
    Arzneimittelforschung; 1997 Aug; 47(8):904-9. PubMed ID: 9296275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional quantitative structure (3-D QSAR) activity relationship studies on imidazolyl and N-pyrrolyl heptenoates as 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) inhibitors by comparative molecular similarity indices analysis (CoMSIA).
    Thilagavathi R; Kumar R; Aparna V; Sobhia ME; Gopalakrishnan B; Chakraborti AK
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1027-32. PubMed ID: 15686906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase.
    Cohen LH; van Vliet A; Roodenburg L; Jansen LM; Griffioen M
    Biochem Pharmacol; 1993 Jun; 45(11):2203-8. PubMed ID: 8517861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis.
    Alberts AW
    Cardiology; 1990; 77 Suppl 4():14-21. PubMed ID: 2073667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-imidazolylchroman-4-ones, N-imidazolyl-1-tetralones, and their alcohols as hypolipemic agents raising high-density lipoproteins.
    Cozzi P; Branzoli U; Lovisolo PP; Orsini G; Carganico G; Pillan A; Chiari A
    J Med Chem; 1986 Mar; 29(3):404-10. PubMed ID: 3950919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of pyrrole-based hepatoselective ligands as potent inhibitors of HMG-CoA reductase.
    Bratton LD; Auerbach B; Choi C; Dillon L; Hanselman JC; Larsen SD; Lu G; Olsen K; Pfefferkorn JA; Robertson A; Sekerke C; Trivedi BK; Unangst PC
    Bioorg Med Chem; 2007 Aug; 15(16):5576-89. PubMed ID: 17560788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RG 12561 (dalvastatin): a novel synthetic inhibitor of HMG-CoA reductase and cholesterol-lowering agent.
    Amin D; Gustafson SK; Weinacht JM; Cornell SA; Neuenschwander K; Kosmider B; Scotese AC; Regan JR; Perrone MH
    Pharmacology; 1993; 46(1):13-22. PubMed ID: 8434028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of cholesterol biosynthesis. 2. 1,3,5-trisubstituted [2-(tetrahydro-4-hydroxy-2-oxopyran-6-yl)ethyl]pyrazoles.
    Sliskovic DR; Roth BD; Wilson MW; Hoefle ML; Newton RS
    J Med Chem; 1990 Jan; 33(1):31-8. PubMed ID: 2296027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile acid derived HMG-CoA reductase inhibitors.
    Kramer W; Wess G; Enhsen A; Bock K; Falk E; Hoffmann A; Neckermann G; Gantz D; Schulz S; Nickau L
    Biochim Biophys Acta; 1994 Nov; 1227(3):137-54. PubMed ID: 7986821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological profile, and quantitative structure-activity relationship of a series of novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Sit SY; Parker RA; Motoc I; Han W; Balasubramanian N; Catt JD; Brown PJ; Harte WE; Thompson MD; Wright JJ
    J Med Chem; 1990 Nov; 33(11):2982-99. PubMed ID: 2231596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of cholesterol biosynthesis. 1. trans-6-(2-pyrrol-1-ylethyl)-4-hydroxypyran-2-ones, a novel series of HMG-CoA reductase inhibitors. 1. Effects of structural modifications at the 2- and 5-positions of the pyrrole nucleus.
    Roth BD; Ortwine DF; Hoefle ML; Stratton CD; Sliskovic DR; Wilson MW; Newton RS
    J Med Chem; 1990 Jan; 33(1):21-31. PubMed ID: 2296019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins.
    Dansette PM; Jaoen M; Pons C
    Exp Toxicol Pathol; 2000 May; 52(2):145-8. PubMed ID: 10965989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of cholesterol biosynthesis. 6. trans-6-[2-(2-N-heteroaryl-3,5-disubstituted- pyrazol-4-yl)ethyl/ethenyl]tetrahydro-4-hydroxy-2H-pyran-2-ones.
    Sliskovic DR; Blankley CJ; Krause BR; Newton RS; Picard JA; Roark WH; Roth BD; Sekerke C; Shaw MK; Stanfield RL
    J Med Chem; 1992 May; 35(11):2095-103. PubMed ID: 1597859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol content of the rat lens is lowered by administration of simvastatin, but not by pravastatin.
    De Vries AC; Vermeer MA; Bredman JJ; Bär PR; Cohen LH
    Exp Eye Res; 1993 Apr; 56(4):393-9. PubMed ID: 8500554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activity of new HMG-CoA reductase inhibitors. 2. Derivatives of 7-(1H-pyrrol-3-yl)-substituted-3,5-dihydroxyhept-6(E)-enoic (-heptanoic) acids.
    Jendralla H; Baader E; Bartmann W; Beck G; Bergmann A; Granzer E; von Kerekjarto B; Kesseler K; Krause R; Schubert W
    J Med Chem; 1990 Jan; 33(1):61-70. PubMed ID: 2153213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.